HC Wainwright reissued their buy rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. EOLS has been the subject of a number of other research reports. Barclays upgraded Evolus from an equal weight rating to an […]
Sandra Beaver: All Smiles for Future of Evolus - Orange County Business Journal ocbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ocbj.com Daily Mail and Mail on Sunday newspapers.
Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Insider Selling: Evolus, Inc. (NASDAQ:EOLS) Insider Sells $204,168.72 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.